December 9, 2016

CAAR – Lancet Article Abstract – December 9, 2016

Filed under: Reports and Articles — Tags: , — admin @ 4:42 pm

Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer’s disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial,” by Prof. Serge Gauthier, Prof. Howard H. Feldman, Prof. Lon S. Schneider, Prof. Gordon K. Wilcock, Prof. Giovanni B. Frisoni, Jiri H. Hardlund, Hans J. Moebius, Peter Bentham, Karin A. Kook, Damon J. Wischik, Prof. Bjoern O. Schelter, and Charles S. Davis, Roger T. Staff, Luc Bracoud, Kohkan Shamsi, Prof. John M. D. Storey, Charles R. Harrington, and Prof. Claude M. Wischik (Vol. 388, No. 10062, December 10, 2016, p. 2873–2884).

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress